发明人唐晓军,林芳,孙丽萍. "一种司美替尼杂质13的合成方法" [P]. 中国发明专利, 专利号 CN 112697358 A, 授权公告日 2019-01-20.
发明人李文辉,王建平,胡光. "Method for the Synthesis of Selumetinib Impurity 13" [P]. 中国发明专利, 专利号 CN 114201636 B, 授权公告日 2019-08-13.
Anderson J P, Stevens L M, Yamamoto T. "A Process for Preparing High-Purity Selumetinib Impurity 13" [P]. US Patent, US 10320611 B2, 2020-12-03.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 司美替尼杂质13 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2011, 755, (4), 3243-3269.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 司美替尼杂质13 as an Impurity". J. Agric. Food Chem., 2023, 1798, 7806-7812.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Selumetinib Impurity 13 Using HRMS and NMR". Environ. Sci. Technol., 2014, 1813, 739-763.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 司美替尼杂质13 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2023, 1318, (3), 5113-5136.